Literature DB >> 24046200

Cannabinoids in exhaled breath following controlled administration of smoked cannabis.

Sarah K Himes1, Karl B Scheidweiler, Olof Beck, David A Gorelick, Nathalie A Desrosiers, Marilyn A Huestis.   

Abstract

BACKGROUND: Δ(9)-Tetrahydrocannabinol (THC), 11-nor-9-carboxy-THC (THCCOOH), and cannabinol (CBN) were measured in breath following controlled cannabis smoking to characterize the time course and windows of detection of breath cannabinoids.
METHODS: Exhaled breath was collected from chronic (≥4 times per week) and occasional (<twice per week) smokers before and after smoking a 6.8% THC cigarette. Sample analysis included methanol extraction from breath pads, solid-phase extraction, and liquid chromatography-tandem mass spectrometry quantification.
RESULTS: THC was the major cannabinoid in breath; no sample contained THCCOOH and only 1 contained CBN. Among chronic smokers (n = 13), all breath samples were positive for THC at 0.89 h, 76.9% at 1.38 h, and 53.8% at 2.38 h, and only 1 sample was positive at 4.2 h after smoking. Among occasional smokers (n = 11), 90.9% of breath samples were THC-positive at 0.95 h and 63.6% at 1.49 h. One occasional smoker had no detectable THC. Analyte recovery from breath pads by methanolic extraction was 84.2%-97.4%. Limits of quantification were 50 pg/pad for THC and CBN and 100 pg/pad for THCCOOH. Solid-phase extraction efficiency was 46.6%-52.1% (THC) and 76.3%-83.8% (THCCOOH, CBN). Matrix effects were -34.6% to 12.3%. Cannabinoids fortified onto breath pads were stable (≤18.2% concentration change) for 8 h at room temperature and -20°C storage for 6 months.
CONCLUSIONS: Breath may offer an alternative matrix for identifying recent driving under the influence of cannabis, but currently sensitivity is limited to a short detection window (0.5-2 h).

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24046200      PMCID: PMC4537523          DOI: 10.1373/clinchem.2013.207407

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  33 in total

Review 1.  The role of alternative specimens in toxicological analysis.

Authors:  E Gallardo; J A Queiroz
Journal:  Biomed Chromatogr       Date:  2008-08       Impact factor: 1.902

2.  High-potency marijuana impairs executive function and inhibitory motor control.

Authors:  Johannes G Ramaekers; Gerhold Kauert; Peter van Ruitenbeek; Eef L Theunissen; Erhard Schneider; Manfred R Moeller
Journal:  Neuropsychopharmacology       Date:  2006-03-29       Impact factor: 7.853

Review 3.  Cannabinoid function in learning, memory and plasticity.

Authors:  G Riedel; S N Davies
Journal:  Handb Exp Pharmacol       Date:  2005

Review 4.  Pharmacokinetics and metabolism of the plant cannabinoids, delta9-tetrahydrocannabinol, cannabidiol and cannabinol.

Authors:  M A Huestis
Journal:  Handb Exp Pharmacol       Date:  2005

5.  Cytochrome P450 enzymes involved in the metabolism of tetrahydrocannabinols and cannabinol by human hepatic microsomes.

Authors:  Kazuhito Watanabe; Satoshi Yamaori; Tatsuya Funahashi; Toshiyuki Kimura; Ikuo Yamamoto
Journal:  Life Sci       Date:  2007-01-17       Impact factor: 5.037

6.  Excretion of Delta9-tetrahydrocannabinol in sweat.

Authors:  Marilyn A Huestis; Karl B Scheidweiler; Takeshi Saito; Neil Fortner; Tsadik Abraham; Richard A Gustafson; Michael L Smith
Journal:  Forensic Sci Int       Date:  2007-05-03       Impact factor: 2.395

7.  Cannabinoids in humans. II. The influence of three methods of hydrolysis on the concentration of THC and two metabolites in urine.

Authors:  P M Kemp; I K Abukhalaf; J E Manno; B R Manno; D D Alford; M E McWilliams; F E Nixon; M J Fitzgerald; R R Reeves; M J Wood
Journal:  J Anal Toxicol       Date:  1995-09       Impact factor: 3.367

8.  Implications of plasma Delta9-tetrahydrocannabinol, 11-hydroxy-THC, and 11-nor-9-carboxy-THC concentrations in chronic cannabis smokers.

Authors:  Erin L Karschner; Eugene W Schwilke; Ross H Lowe; W David Darwin; Ronald I Herning; Jean Lud Cadet; Marilyn A Huestis
Journal:  J Anal Toxicol       Date:  2009-10       Impact factor: 3.367

9.  Detection of conjugated 11-nor-Delta9-tetrahydrocannabinol-9-carboxylic acid in oral fluid.

Authors:  Christine Moore; Sumandeep Rana; Cynthia Coulter; David Day; Michael Vincent; James Soares
Journal:  J Anal Toxicol       Date:  2007-05       Impact factor: 3.367

10.  Metabolism of delta 9-tetrahydrocannabinol by cytochrome P450 isozymes purified from hepatic microsomes of monkeys.

Authors:  T Matsunaga; Y Iwawaki; K Watanabe; I Yamamoto; T Kageyama; H Yoshimura
Journal:  Life Sci       Date:  1995       Impact factor: 5.037

View more
  10 in total

Review 1.  The state of clinical outcome assessments for cannabis use disorder clinical trials: A review and research agenda.

Authors:  Mallory J E Loflin; Brian D Kiluk; Marilyn A Huestis; Will M Aklin; Alan J Budney; Kathleen M Carroll; Deepak Cyril D'Souza; Robert H Dworkin; Kevin M Gray; Deborah S Hasin; Dustin C Lee; Bernard Le Foll; Frances R Levin; Joshua A Lile; Barbara J Mason; Aimee L McRae-Clark; Ivan Montoya; Erica N Peters; Tatiana Ramey; Dennis C Turk; Ryan Vandrey; Roger D Weiss; Eric C Strain
Journal:  Drug Alcohol Depend       Date:  2020-04-26       Impact factor: 4.492

2.  Determination of Cannabinoid Vapor Pressures to Aid in Vapor Phase Detection of Intoxication.

Authors:  Tara M Lovestead; Thomas J Bruno
Journal:  Forensic Chem       Date:  2017-06-27

3.  Examining impairment and kinetic patterns associated with recent use of hemp-derived Δ8-tetrahydrocannabinol: case studies.

Authors:  Gregory T Wurz; Edward Montoya; Michael W DeGregorio
Journal:  J Cannabis Res       Date:  2022-07-07

4.  Indeterminacy of cannabis impairment and ∆9-tetrahydrocannabinol (∆9-THC) levels in blood and breath.

Authors:  Gregory T Wurz; Michael W DeGregorio
Journal:  Sci Rep       Date:  2022-05-18       Impact factor: 4.996

5.  In reply.

Authors:  Sarah K Himes; Marilyn A Huestis
Journal:  Clin Chem       Date:  2014-07-18       Impact factor: 8.327

6.  The Effects of Acute Cannabis Use on Nontraffic Injury Risk: Reviewing the Available Literature and Identifying Ways Forward.

Authors:  Gabriel Andreuccetti; Yu Ye; Jaewook Kang; Rachael Korcha; Jane A Witbrodt; Heraclito B Carvalho; Cheryl J Cherpitel
Journal:  Contemp Drug Probl       Date:  2017-06-30

7.  Measuring Within-Individual Cannabis Reduction in Clinical Trials: A Review of the Methodological Challenges.

Authors:  Rachel L Tomko; Kevin M Gray; Marilyn A Huestis; Lindsay M Squeglia; Nathaniel L Baker; Erin A McClure
Journal:  Curr Addict Rep       Date:  2019-11-19

Review 8.  Establishing legal limits for driving under the influence of marijuana.

Authors:  Kristin Wong; Joanne E Brady; Guohua Li
Journal:  Inj Epidemiol       Date:  2014-10-29

9.  Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.

Authors:  Mario Thevis; Oliver Krug; Hans Geyer; Wilhelm Schänzer
Journal:  Rapid Commun Mass Spectrom       Date:  2017-08-15       Impact factor: 2.419

10.  A comprehensive breath test that confirms recent use of inhaled cannabis within the impairment window.

Authors:  Michael W DeGregorio; Gregory T Wurz; Edward Montoya; Chiao-Jung Kao
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.